Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide

被引:11
作者
Buerth, Christoph [1 ]
Mausberg, Anne K. [2 ]
Heininger, Maximilian K. [2 ]
Hartung, Hans-Peter [2 ]
Kieseier, Bernd C. [2 ]
Ernst, Joachim F. [1 ]
机构
[1] Univ Dusseldorf, Dept Biol, Inst Mol Mycol, Dusseldorf, Germany
[2] Univ Dusseldorf, Fac Med, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Dusseldorf, Germany
关键词
MYELIN BASIC-PROTEIN; CELL-SURFACE DISPLAY; SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; ACTINOBACILLUS-PLEUROPNEUMONIAE; ENCEPHALITOGENIC ANTIGENS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; IN-VITRO; GM-CSF;
D O I
10.1371/journal.pone.0155082
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multiple sclerosis (MS) is an autoimmune disease that attacks myelinated axons in the central nervous system. Induction of oral tolerance is a potent mechanism to prevent autoimmunity. The food yeast Candida utilis was used to test the therapeutic potential of oral tolerance induction in an animal model of human multiple sclerosis (MS). We constructed a C. utilis strain, which displays a fusion peptide composed of the encephalitogenic MOG(35-55) peptide and the C. utilis Gas1 cell wall protein on its surface. By immunizing mice with MOG(35-55) peptide experimental autoimmune encephalomyelitis (EAE) was induced in a mouse model. Feeding of mice with C. utilis that expresses MOG(35-55) peptide on its surface was started seven days prior to immunization and was continued for ten days. Control animals were treated with wild-type fungus or left untreated. Untreated mice developed first clinical symptoms ten days post immunization (p. i.) with an ascending paralysis reaching maximal clinical disability at day 18 to 20 p. i.. Treatment with the wild-type strain demonstrated comparable clinical symptoms. In contrast, oral gavage of MOG(35-55)-presenting fungus ameliorated the development of EAE. In addition, incidence as well as maximal clinical disease severity were significantly reduced. Interestingly, reduction of disease severity also occurred in animals treated with heat-inactivated C. utilis cells indicating that tolerance induction was independent of fungal viability. Better disease outcome correlated with reduced demyelination and cellular inflammation in the spinal cord, lower T cell proliferation against rechallenge with MOG(35-55) and more regulatory T cells in the lymph nodes. Our data demonstrate successful that using the food approved fungus C. utilis presenting the immunogenic MOG(35-55) peptide on its surface induced an oral tolerance against this epitope in EAE. Further studies will reveal the nature and extent of an anti-inflammatory environment established by the treatment that prevents the development of an autoimmune disorder affecting the CNS.
引用
收藏
页数:17
相关论文
共 40 条
[1]   Vaccines based on whole recombinant Saccharomyces cerevisiae cells [J].
Ardiani, Andressa ;
Higgins, Jack P. ;
Hodge, James W. .
FEMS YEAST RESEARCH, 2010, 10 (08) :1060-1069
[2]   GM-CSF: An immune modulatory cytokine that can suppress autoimmunity [J].
Bhattacharya, Palash ;
Thiruppathi, Muthusamy ;
Elshabrawy, Hatem A. ;
Alharshawi, Khaled ;
Kumar, Prabhakaran ;
Prabhakar, Bellur S. .
CYTOKINE, 2015, 75 (02) :261-271
[3]   Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress Experimental Autoimmune Encephalomyelitis either at the priming or at the effector phase [J].
Bhowmick, Sourojit ;
Clark, Robert B. ;
Brocke, Stefan ;
Cone, Robert E. .
INTERNATIONAL IMMUNOLOGY, 2011, 23 (02) :119-128
[4]   SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY THE ORAL-ADMINISTRATION OF MYELIN BASIC-PROTEIN [J].
BITAR, DM ;
WHITACRE, CC .
CELLULAR IMMUNOLOGY, 1988, 112 (02) :364-370
[5]   Growth-dependent secretome of Candida utilis [J].
Buerth, Christoph ;
Heilmann, Clemens J. ;
Klis, Frans M. ;
de Koster, Chris G. ;
Ernst, Joachim F. ;
Tielker, Denis .
MICROBIOLOGY-SGM, 2011, 157 :2493-2503
[6]   Multiple sclerosis [J].
Compston, A ;
Coles, A .
LANCET, 2002, 359 (9313) :1221-1231
[7]   GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage [J].
Croxford, Andrew L. ;
Spath, Sabine ;
Becher, Burkhard .
TRENDS IN IMMUNOLOGY, 2015, 36 (10) :651-662
[8]   Sampling of Candida albicans and Candida tropicalis by Langerin-positive dendritic cells in mouse Peyer's patches [J].
De Jesus, Magdia ;
Rodriguez, Adam E. ;
Yagita, Hideo ;
Ostroff, Gary R. ;
Mantis, Nicholas J. .
IMMUNOLOGY LETTERS, 2015, 168 (01) :64-72
[9]   Oral tolerance: Therapeutic implications for autoimmune diseases [J].
Faria, Ana M. C. ;
Weiner, Howard L. .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2006, 13 (2-4) :143-157
[10]   In vitro-induced cell-mediated immune deviation to encephalitogenic antigens [J].
Farooq, Shukkur M. ;
Ashour, Hossam M. .
BRAIN BEHAVIOR AND IMMUNITY, 2014, 35 :64-69